FibroCentriX has worldwide rights to a recent biochemical breakthrough solution that has been found to alleviate connective tissue pain for those who suffer with chronic Fibro pain conditions. The applied FibroCentriX care protocol has placed chronic pain into remission for those whose conditions have been otherwise unaffected or deemed incurable by conventional means. To complement this exciting news, the FibroCentriX® practitioner based Affiliate network is rapidly growing across the United States. These highly trained health and wellness professionals will be strategically positioned across the country to implement specialized testing and administrate these promising care protocols.
| Website | http://www.fibrocentrix.com |
| Revenue | $5.9 million |
| Employees | 2 (0 on RocketReach) |
| Founded | 2014 |
| Address | 51 Woodridge Ln, Fulton, New York 13069, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+1 more
(view full list)
|
| Industry | Health, Wellness and Fitness, Hospitals & Clinics, Healthcare |
| Keywords | Fibromyalgia Treatment, Chronic Pain Treatment, Innovative Pain Therapy, Musculoskeletal Pain, Pain Management Solutions, Regenerative Medicine, Advanced Pain Care, Non-Opioid Pain Relief, Holistic Pain Management, Alternative Pain Management |
| Competitors | Amgen, Invitae, Mesoblast Limited, Athersys, Tissue Regenix Group, NantKwest, Lorem Cytori USA, Inc, Soligenix, Inc., Zynerba Pharmaceuticals, StemCells, Inc. +36 more (view full list) |
| SIC | SIC Code 80 Companies, SIC Code 804 Companies |
| NAICS | NAICS Code 62 Companies, NAICS Code 621 Companies, NAICS Code 6213 Companies, NAICS Code 621399 Companies, NAICS Code 62139 Companies |
Looking for a particular FibroCentriX employee's phone or email?
FibroCentriX Questions
The FibroCentriX annual revenue was $5.9 million in 2026.
FibroCentriX is based in Fulton, New York.
The NAICS codes for FibroCentriX are [62, 621, 6213, 621399, 62139].
The SIC codes for FibroCentriX are [80, 804].
Related Companies
